Gabon vs Malaysia: HIV/AIDS deaths averted by antiretroviral therapy
Gabon
2,398 deaths
in 2024
Malaysia
2,430 deaths
in 2024
Gabon rank
53rd
Malaysia rank
52nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Gabon
- Malaysia
How they compare
Malaysia currently reports 2,430 deaths against 2,398 deaths in Gabon, a difference of 32 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Malaysia ahead.
Gabon ranks 53rd and Malaysia ranks 52nd of 157 countries.
Across the 4 decades both report, Gabon averaged higher in 1 and Malaysia in 3.
Head to head by decade
| Decade | Gabon | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 2.35 deaths | 2.35 deaths | Malaysia |
| 2000s | 658.44 deaths | 917.24 deaths | 258.8 deaths | Malaysia |
| 2010s | 2,011 deaths | 1,987 deaths | 24.35 deaths | Gabon |
| 2020s | 2,106 deaths | 2,627 deaths | 520.27 deaths | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Gabon or Malaysia?
- Malaysia, at 2,430 deaths against 2,398 deaths in Gabon as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Gabon and Malaysia?
- 32 deaths, with Malaysia ahead.
- How many years of comparable data are there for Gabon and Malaysia?
- 35 years are reported by both, from 1990 to 2024.
- How do Gabon and Malaysia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Gabon ranks 53rd and Malaysia ranks 52nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.